Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients;Stêżenia transformuj1cego czynnika wzrostu β1 i białka C-reaktywnego u chorych na migrenê

Neurologia i Neurochirurgia Polska

Volumn 47, Issue 4, 2013, Pages 357-362

  Güzel, Işil ^a   Taşdemir, Nebahat ^a   Çelik, Yusuf ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aetiology; CRP; Migraine; Neurogenic inflammation; TGF 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CLINICAL EVALUATION; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIGRAINE; MIGRAINE AURA; NEUROGENIC INFLAMMATION; OCCUPATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL STATUS;

EID: 84881503618     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2013.36760     Document Type: Article

References (24)

1. Arulmozhi D.K., Veeranjaneyulu A., Bodhankar S. Migraine: current concepts and emerging therapies. Vasc Pharmacol 2005; 43: 176-187.
2. Cutter F.M., Sorenson A.G., Weisskoff R.M., et al. Perfusionweighted imaging defects during spontaneous migraine aura. Ann Neurol 1998; 43: 25-31.
3. Lance J.W. Current concepts of migraine pathogenesis. Neurology 1993; 43 (Suppl 3): 11-15.
4. Appenzeller O. Pathogenesis of migraine. Med Clin North Am 1991; 75: 763-789.
5. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43 (6 Suppl 3): S16-S20.
6. Dalessio D.J. Vascular permeability and vasoactive substances: their relationship to migraine. Adv Neurol 1974; 4: 395-401.
7. Knoflach M., Kiechl S., Kind M., et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 2003; 108: 1064-1069.
8. Munno I., Marinaro M., Bassi A., et al. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache 2001; 41: 764-767.
9. Yasunari K., Maeda K., Nakamura M. Oxidative stress in leu kocytes is a possible link between blood pressure, blood glucose, and C-reactive protein. Hypertension 2002; 39: 777-780.
10. Clark D.A., Coker R. Transforming growth factor-beta (TGFbeta). Int J Biochem Cell Biol 1998; 30: 293-298.
11. Marek A., Brodzicki J., Liberek A., et al. TGFbeta (transforming growth factor-beta) in chronic inflammatory conditions - a new diagnostic and prognostic marker? Med Sci Monit 2002; 8: RA145-RA151.
12. D'Andrea G., Cananzi A.R., Perini F., et al. Platelet models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia 1995; 15: 265-271.
13. Kemper R.H., Meijler W.J., Korf J., et al. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001; 21: 549-557.
14. nd ed. Cephalalgia 2004; 1: 24.
15. Monastero R., Pipia C., Cefalu A.B., et al. Association between plasma lipid levels and migraine in subjects aged > or =50 years: preliminary data from the Zabut Aging Project. Neurol Sci 2008; 29 (Suppl 1): S179-S181.
16. Camarda C., Monastero R., Pipia C., et al. Interictal executive dysfunction in migraineurs without aura: relationship with duration and intensity of attacks. Cephalalgia 2007; 27: 1094-1100.
17. Celik Y. Biostatistics, principles of research. Dicle University Press, Diyarbakir 2007.
18. Moskowitz M.A. The neurobiology of vascular head pain. Ann Neurol 1984; 16: 157-168.
19. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987; 7: 4129-4136.
20. Durham P.L. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006; 46 (Suppl 1): S3-S8.
21. Vanmolkot F.H., de Hoon J.N. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 2007; 27: 843-846.
22. Welch K.M., Brandes A.W., Salerno L., et al. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006; 46: 197-199.
23. Ishizaki K., Takeshima T., Fukuhara Y., et al. Increased plasma transforming growth factor-beta1 in migraine. Headache 2005; 45: 1224-1228.
24. Thompson D., Pepys M.B., Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999; 15: 169-177.